Cargando…

The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study

BACKGROUND: It is essential to determine the distribution of the causative microorganisms in the region and the status of local antibiotic resistance for the proper treatment of hospital-acquired pneumonia/ventilator-associated pneumonia (HAP/VAP). This study aimed to investigate the occurrence and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Youjin, Jeon, Kyeongman, Lee, Sang-Min, Cho, Young-Jae, Kim, Young Sam, Chong, Yong Pil, Hong, Sang-Bum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546312/ https://www.ncbi.nlm.nih.gov/pubmed/34697926 http://dx.doi.org/10.3346/jkms.2021.36.e251

Ejemplares similares

Characteristics, Management, and Clinical Outcomes of Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: A Multicenter Cohort Study in Korea
por: Ko, Ryoung-Eun, et al.
Publicado: (2021)

The current pathogens and treatment of hospital-acquired pneumonia/ventilator-associated pneumonia in medical intensive care units
por: Chang, Y, et al.
Publicado: (2015)

Impact of nutrition and physical activity on outcomes of hospital-acquired pneumonia
por: Jang, Jin Ho, et al.
Publicado: (2022)

A Case of Community-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii in Korea
por: Son, Young Woong, et al.
Publicado: (2017)

Microbiologic pattern and clinical outcome of non-ICU-acquired pneumonia: Korean HAP registry analysis
por: Jang, Jin Ho, et al.
Publicado: (2023)

Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia
por: Jung, Yun Jung, et al.
Publicado: (2022)

Community versus hospital-acquired pneumonia in patients requiring extracorporeal membrane oxygenation
por: Park, Chul, et al.
Publicado: (2019)

Microbiologic pattern and clinical outcome of non-ICU-acquired pneumonia: Korean HAP registry analysis
por: Jang, Jin Ho, et al.
Publicado: (2022)

Failure of High-Flow Nasal Cannula Therapy in Pneumonia and Non-Pneumonia Sepsis Patients: A Prospective Cohort Study
por: Kim, Eunhye, et al.
Publicado: (2021)

Comparison of Cefepime with Piperacillin/Tazobactam Treatment in Patients with Hospital-Acquired Pneumonia
por: Kim, Bo-Guen, et al.
Publicado: (2023)

Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
por: Motowski, Hayley, et al.
Publicado: (2023)

Comparison of the end-of-life decisions of patients with hospital-acquired pneumonia after the enforcement of the life-sustaining treatment decision act in Korea
por: Baek, Ae-Rin, et al.
Publicado: (2023)

Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients
por: Kim, Won-Young, et al.
Publicado: (2016)

Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia
por: Kim, Bo-Guen, et al.
Publicado: (2022)

Risk factors for infection with multidrug-resistant bacteria in non-ventilated patients with hospital-acquired pneumonia,
por: Seligman, Renato, et al.
Publicado: (2013)

Prognosis of hospital‐acquired pneumonia/ventilator‐associated pneumonia with Stenotrophomonas maltophilia versus Klebsiella pneumoniae in intensive care unit: A retrospective cohort study
por: Chen, Shuping, et al.
Publicado: (2022)

Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?
por: Vallecoccia, Maria Sole, et al.
Publicado: (2020)

Empiric Anti-Pseudomonal β-Lactam Monotherapy Versus Fluoroquinolone Combination Therapy in Patients With Hospital-Acquired Pneumonia: A Multicenter Cohort Study With Propensity Score Matching
por: Baek, Moon Seong, et al.
Publicado: (2023)

Ventilator associated pneumonia in a medical intensive care unit: Microbial aetiology, susceptibility patterns of isolated microorganisms and outcome
por: Goel, Varun, et al.
Publicado: (2012)

Outcomes of severe human metapneumovirus-associated community-acquired pneumonia in adults
por: Choi, Sang-Ho, et al.
Publicado: (2019)

Intensive Care Unit Relocation and Its Effect on Multidrug-Resistant Respiratory Microorganisms
por: Kim, Hyung-Jun, et al.
Publicado: (2018)

Ventilator-associated pneumonia caused by multidrug resistant bacteria
por: Sartzi, M, et al.
Publicado: (2005)

Cytokine Activation Patterns and Biomarkers Are Influenced by Microorganisms in Community-Acquired Pneumonia
por: Menéndez, Rosario, et al.
Publicado: (2012)

Severe community-acquired pneumonia in the intensive care unit
por: Costa, C, et al.
Publicado: (2005)

Profile of infective microorganisms causing ventilator-associated pneumonia: A clinical study from resource limited intensive care unit
por: Thakuria, Bhaskar, et al.
Publicado: (2013)

Intensive care unit-acquired hyponatremia in critically ill medical patients
por: Sim, Jae Kyeom, et al.
Publicado: (2020)

Serologic Prevalence of Amoeba-Associated Microorganisms in Intensive Care Unit Pneumonia Patients
por: Bousbia, Sabri, et al.
Publicado: (2013)

Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes
por: Hyun, Hakjun, et al.
Publicado: (2022)

Metagenomics for the microbiological diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia (HAP/VAP) in intensive care unit (ICU): a proof-of-concept study
por: Heitz, Morgane, et al.
Publicado: (2023)

What is new in non-ventilated ICU-acquired pneumonia?
por: Saied, Wafa Ibn, et al.
Publicado: (2020)

Viruses are prevalent in non-ventilated hospital-acquired pneumonia
por: Shorr, Andrew F., et al.
Publicado: (2017)

Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2020)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, C., et al.
Publicado: (2018)

Comparison of viral infection in healthcare-associated pneumonia (HCAP) and community-acquired pneumonia (CAP)
por: Kim, Eun Sun, et al.
Publicado: (2018)

Clinical Implication of Candida Score in Multidrug-Resistant Pneumonia with Airway Candida Colonization
por: La, Yeonju, et al.
Publicado: (2022)

1476. Objective Surveillance Definitions for Hospital-Acquired Pneumonia in Non-Ventilated Patients
por: Ji, Wenjing, et al.
Publicado: (2018)

Frequency of Ventilator Associated Pneumonias in Patients in the Intensive Care Unit
por: Suljevic, Ismet, et al.
Publicado: (2020)

Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia
por: Lee, Hongyeul, et al.
Publicado: (2016)

The clinical significance of changes in red blood cell distribution width in patients with community-acquired pneumonia
por: Lee, Sang-Min, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2fid2a2l91snuokcejmlfuhj8s